Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
192.75
-3.17 (-1.62%)
Aug 27, 2026, 12:20 PM EDT - Market open

Nutex Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
179.9270.7952.1-45.79-424.78132.59
Depreciation & Amortization
2120.5318.9717.5913.137.66
Other Amortization
0.440.91.041.211.950.05
Asset Writedown & Restructuring Costs
--7.5430.22398.14-
Stock-Based Compensation
9.5811716.562.840.19-
Other Operating Activities
63.97126.6431.19-3.29-2.3430.37
Change in Accounts Receivable
-1.7-89.32-173.41-4.5858.08-6.62
Change in Inventory
-1.93-0.020.540.14-0.72-1.09
Change in Accounts Payable
15.8637.85-10.72-2.259.696.27
Change in Income Taxes
-4.36-25.6726.53---
Change in Other Net Operating Assets
-3.16-10.652.825.16-2.734.2
Operating Cash Flow
279.62248.1323.151.2650.61173.43
Operating Cash Flow Growth
228.72%971.67%1741.93%-97.52%-70.82%100.10%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-7.77-6.84-2.3-9.5-14.63-36.93
Cash Acquisitions
----0.712.72-
Divestitures
---0.36-1.04-2.42-0.05
Other Investing Activities
-1.351.6-2.94---
Investing Cash Flow
-9.12-5.24-5.61-11.24-4.34-36.98

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5.042.262.342.62-
Long-Term Debt Issued
--7.0221.860.8219.61
Total Debt Issued
0.185.049.2824.23.4419.61
Short-Term Debt Repaid
--7.86-2.08-1.59-0.07-0.86
Long-Term Debt Repaid
--16.63-14.6-19.96-8.96-21.97
Total Debt Repaid
-22.8-24.48-16.68-21.56-9.03-22.84
Net Debt Issued (Repaid)
-22.63-19.44-7.42.65-5.59-3.22
Issuance of Common Stock
2.010.7714.930.39.2821.75
Repurchase of Common Stock
-55.69-5----
Common Dividends Paid
-----34.35-111.69
Other Financing Activities
-84.12-74.28-6.44-5.22-17.47-32.69
Financing Cash Flow
-160.43-97.951.09-2.27-48.13-125.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
110.08144.9318.64-12.25-1.8610.6

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
271.85241.2920.85-8.2435.97136.51
Free Cash Flow Growth
234.62%1057.31%---73.65%435.68%
Free Cash Flow Margin
32.11%27.57%4.34%-3.33%16.41%41.17%
Free Cash Flow Per Share
38.1235.713.80-1.878.5034.54
Levered Free Cash Flow
130.75152.8113.180.4753.481.1
Unlevered Free Cash Flow
142.67165.824.69.4659.2684.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.542.513.471.644.624.1
Cash Income Tax Paid
51.4272.820.80.858.230.34
Change in Working Capital
4.71-87.74-104.24-1.5364.322.75
SEC Filings: 10-K · 10-Q